About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
COMPANY NEWS
Company
News
Pfizer Ltd.
Change Company
BSE Code
500680
ISIN Demat
INE182A01018
Book Value
841.20
NSE Code
PFIZER
Dividend Yield %
3.59
Market Cap
210176.52
P/E
25.04
EPS
183.46
Face Value
10
1 Week
1 Month
3 Months
6 Months
1 Year
20-Jan-2026
Pfizer informs about change in senior management...
19-Dec-2025
Pfizer enters into marketing, distribution agreem...
19-Dec-2025
Pfizer informs about press release
18-Nov-2025
Pfizer inches up on launching new medication for ...
17-Nov-2025
Pfizer launches new medication for migraine treat...
05-Sep-2025
Pfizer signs MoU with DPIIT
12-Aug-2025
Pfizer launches 20-valent Pneumococcal Conjugate ...
12-Aug-2025
Pfizer surges on launching 20-valent Pneumococcal...
19-Mar-2025
Pfizer informs about disclosures
24-Feb-2025
Pfizer zooms on getting nod to enter into Marketi...
21-Feb-2025
Pfizer gets nod to enter into Marketing and Suppl...
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.